Vanguard Capital Management »

Forte Biosciences shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 532k 25.90

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Forte Biosciences

Federated Investors
Fred Alger Management
OrbiMed Advisors
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
Vanguard Group
Vanguard Capital Management
Morgan Stanley
Cable Car Capital
Millennium Management
Adage Capital Partners GP
Woodline Partners
FMR
Citadel Advisors

View all funds holding Forte Biosciences